The Oncology Institute (TOI) Stock: Buy, Sell, or Hold?
TOI - The Oncology Institute, Inc. Common Stock
$5.13
0.27 (5.56%)
â˛
5d:
-1.16%
30d:
-2.84%
90d:
+26.67%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TOI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TOI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TOI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TOI is currently trading at $5.13, which is considered fair based on recent price action.
Technical Outlook: Technically, TOI is in a strong uptrend. Immediate support is located at $4.70, while resistance sits at $5.59. The stock is showing strong short-term momentum, up 5.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.40 (+72.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TOI is in a strong uptrend. Immediate support is located at $4.70, while resistance sits at $5.59. The stock is showing strong short-term momentum, up 5.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.40 (+72.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
51/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+5.6%)
- BULLISH: Trading 72.8% below Wall St target ($8.40)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$4.70
Resistance Level
$5.59
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-194.40
Wall Street Target
$8.40
(+72.8%)
Revenue Growth (YoY)
41.2%
Profit Margin
-8.0%
Share & Embed Analysis
Last updated: September 13, 2026 5:50 AM ET
Data refreshes hourly during market hours. Next update: 6:50 AM
Data refreshes hourly during market hours. Next update: 6:50 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TOI showing a specific setup today?
Insider Activity (6 Months)
3
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mohit Kaushal
SELL
38433 shares
2026-04-16
Mohit Kaushal
SELL
57286 shares
2026-04-14
Jorey Chernett
BUY
20000 shares
2026-04-09
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
